Skip to main content

Christian Rommel, Ph.D.

Equibles does not estimate personal net worth.

Get an email with a short summary when CRISPR Therapeutics AG publishes a filing, an earnings call transcript or a press release.

Get CRSP alerts

About Christian Rommel, Ph.D.

Christian Rommel, Ph.D. is recorded as Board Member at CRISPR Therapeutics AG (CRSP) since May 30, 2024. CRISPR Therapeutics AG reported in an 8-K filed June 3, 2024 that Christian Rommel, Ph.D. was appointed member of the Company's Board of Directors, effective May 30, 2024. CRISPR Therapeutics AG is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at CRISPR Therapeutics AG includes Samarth Kulkarni (CEO), Samarth Kulkarni, Ph.D. (Chairman), Andrew J. Silver (CFO and Chief Accounting Officer) and 7 others.

“Sandesh Mahatme, LL.M. and Christian Rommel, Ph.D., were duly elected as members of the Company's Board of Directors.”
CRISPR Therapeutics AG Form 8-K, filed June 3, 2024 · Read the filing

Affiliation history

Company network

Leadership on record at CRISPR Therapeutics AG

Recent activity